Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BNY).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - EU Market Recap: FTSE 100 +0.99% to 10656.28, DAX +0.76% to 25277.68, CAC40 +0.38% to 7832.88, STOXX 600 +0.65% to 635.65

Oct 12 ,2026

  • Synopsis:

    • European equity markets closed higher Monday, just off afternoon highs. Follows mixed performance last week as France, Germany and Italy lagged while UK and Swiss markets outperformed. Financials, utilities and food&beverage were the outperforming sectors whilst telecom, technology and chemicals lagged.

    • Risk sentiment holding up despite ramp in Middle East hostilities over the weekend and tech weakness in Korea overnight. When it comes to the energy, some focus on continued flow normalization and Trump's claim of an energy ceasefire between Russia and Ukraine (though neither side has confirmed) and Russia reportedly struck Ukrainian power plants post Trump truce announcement. Lot of attention on Houthi attacks on Saudi Arabia risking widening of conflict. Also some attention on reports of commercial tanker attacks in Gulf of Oman and SoH over the weekend.

    • Focus remains on fiscal pressure, though bond market stabilization that kicked off toward latter half of last week extending into Monday's session. Not a lot new out of France over the weekend other than MEP Glucksmann winning French center-left primary, raising odds of further political fragmentation ahead of 2027 presidential election. Trade developments in the spotlight as EU and China avoided a trade confrontation as Beijing agreed to halve hybrid car exports over four years and offered rare earths "green channel".

    • In the UK, focus on Chancellor Healey's October Budget with think tank noting ~£35B funding gap issues. Fiscal concerns remain broader issue in the EU as Ireland's scaled-back 2028-2034 budget proposal faces opposition from several member states.

    • On the reporting front, few trading updates out this morning, including Nordex (NDX1.GR), Hays (HAS.LN) and Vår Energi (VAR.NO). Also in the Nordics, Telia Co. (TELIA.SS) proposed further localization of operations and targets SEK 1B in annual gross savings. Of note, shares in Philips (PHIA.NA) are trading modestly lower after the FDA issued early alert on recall of Philips Lumify Ultrasound system.

  • Digest:

    • Sectors - STOXX Europe 600:

      • Outperformers:

        • Banks +1.50%, Utilities +1.32%, Food & Beverage +1.01%, Persnl & HHold Goods +0.89%, Insurance +0.79%, Ind Goods & Svcs +0.76%, Construct & Mtls +0.74%, Health Care +0.69%

      • Underperformers

        • Telecom (0.54%), Technology (0.41%), Chemicals (0.25%), Travel & Leisure +0.08%, Autos & Parts +0.12%, Basic Resources +0.35%, Media +0.38%, Financial Svcs +0.47%, Real Estate +0.51%, Retail +0.54%, Oil & Gas +0.65%

    • Macro:

      • Geopolitics:

        • UK, Germany and Poland reaffirm full support for Zelenskyy after Trump call for new Ukrainian leader (Politico)

        • Poland's Sikorski warns NATO must prepare for possible deadly Russian hybrid attack (FT)

        • China and EU agree to discuss inverter import restrictions after hybrid vehicle deal (Bloomberg)

        • EU to cap hybrid vehicle imports at 350,000 a year from December under deal with China (Bloomberg)

        • IEA urges members to accelerate diesel releases as global markets tighten (Bloomberg)

      • France:

        • France's bond market turmoil raises risk of contagion across the Eurozone (Bloomberg)

        • Raphaël Glucksmann wins French center-left primary with over 66% of votes (Politico)

      • Germany:

        • German CDU/CSU to press von der Leyen with 27-point plan for EU competitiveness and cheaper power for firms (Handelsblatt)

        • Bundesbank's Theurer warns risks of European sovereign debt crisis have risen significantly (Handelsblatt)

      • Italy:

        • Italian economy held up to shocks but growth is weak says Meloni (ansa)

      • UK:

        • IFS says Chancellor Healey needs £36B in tax rises or cuts to offset inflation and fund defence pledge (Reuters, BBC, Telegraph)

        • Labour set to broaden definition of "British" defence company to include foreign-owned firms with UK presence (Telegraph)

        • Healey to emphasise budget discipline and resilience at IMF meetings in Bangkok (Reuters)

    • Company news:

      • Notable Gainers

        • +22.7% BOR.LN (Borders & Southern Petroleum £0.10, +0.02) -- £2 million fundraising

        • +16.9% AL2SI.FP (2CRSI €29.00, +4.20) -- preliminary sale agreement for Dumarey Powerglide industrial site

        • +9.1% ALVIO.FP (Valerio Therapeutics €0.45, +0.04) -- completes acquisition of Etherna Immunotherapies

        • +7.0% ALDVI.FP (Advicenne €0.71, +0.05) -- cash runway extended to 2028

        • +4.8% IDIA.SW (Idorsia CHF4.40, +0.20) -- new Aprocitentan data in patients with obesity and cardiometabolic disease

        • +4.8% FLS.DC (FLSmidth & Co. DKK594.00, +27.00) -- DKK225M order

        • +3.9% VK.FP (Vallourec €18.59, +0.70) -- major contract

        • +3.4% HTWS.LN (Helios Towers £2.23, +0.07)

        • +3.4% NDX1.GR (Nordex €36.62, +1.20) -- Q3 order intake

        • +3.0% KIN.BB (Kinepolis Group €51.50, +1.50) -- Estimated weekend box office revenues in US, Canada $84.4M, +20.2% y/y - Box Office Mojo

        • +2.7% CWK.LN (Cranswick £51.20, +1.35) -- Peel Hunt upgrade

        • +2.5% CARL.B.DC (Carlsberg DKK895.40, +21.60) -- Barclays upgrade

        • +2.2% INW.IM (Infrastrutture Wireless Italiane €7.18, +0.15) -- Leading shareholders in INWIT line up financing for possible take-private -- Reuters, citing sources (11-Oct)

        • +2.0% NEX.FP (Nexans €131.90, +2.60) -- Jefferies upgrade

        • +1.6% PARRO.FP (Parrot €7.69, +0.12) -- strengthens position in U.S. Army drone procurement programs

        • +1.4% ITM.LN (ITM Power £0.95, +0.01) -- subsidiary Hydropulse signs Heads of Terms for 150 MW project

        • +1.3% SDLF.LN (Standard Life £8.60, +0.11) -- RBC Capital Markets upgrade

      • Notable Decliners

        • -20.9% ACE.SS (Ascelia Pharma SEK0.68, -0.18) -- Orviglance update

        • -11.9% HAS.LN (Hays Plc £0.57, -0.08) -- Q1 update

        • -5.6% AT1.GR (Aroundtown €1.40, -0.08) -- Goldman Sachs downgrade

        • -2.5% AD.NA (Koninklijke Ahold Delhaize €31.46, -0.82) -- cybersecurity incident

        • -2.2% VBK.GR (Verbio €26.30, -0.60)

        • -2.2% POLR.LN (Polar Capital Holdings £7.87, -0.18) -- 3M AuM

    • EU companies reporting tomorrow:

      • Earnings:

        • Nordics: ABG Sundal Collier Holding (ABG.NO)

        • UK: Bellway (BWY.LN), Bytes Technology Group (BYIT.LN), YouGov (YOU.LN)

      • Trading Update:

        • DACHs: Givaudan (GIVN.SW), Sulzer (SUN.SW)

        • France: Ekinops (EKI.FP)

        • UK: BP (BP.LN), Greencore Group (GNC.LN), Rio Tinto (RIO.LN), Oxford Instruments (OXIG.LN), Ninety One (N91.LN), Integrafin Holdings (IHP.LN)

      • Sales: DFDS (DFDS.DC)

      • Traffic: Fraport AG Frankfurt Airport Services Worldwide (FRA.GR), Flughafen Wien (FLU.AV)

      • CMD/Events: Lonza (LONN.SW), Bayerische Motoren Werke (BMW.GR) pre-close call, Ahold (AD.NA) EGM

  • Data:

    • Economics:

      • None

    • Markets:

      • WTI Crude (Nov 26): +$1.85 or +2.01% to $93.70

      • €-$ (0.0027) or (0.24%) to 1.1164

      • £-$ (0.0020) or (0.15%) to 1.3210

      • €-£ (0.0007) to 0.8453

      • S&P 500 (0.03%)

      • Performance year-to-date

        • FTSE 100: +7.30%

        • DAX: +3.21%

        • CAC: (3.89%)

        • MIB: +11.33%

        • Stoxx 600: +7.34%

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE

    • BNY.com Terms of Use Privacy Cookie Notice Manage Cookies Disclaimer CUSIP Disclaimer

    • ©  2025 The Bank of New York Corporation. Depositary Receipt business and services are conducted through The Bank of New York.